Gary T. Jennings

Medicine · Health Sciences

31h-index6.6kcitations47works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Influenza Virus Research Studies(8), Immunotherapy and Immune Responses(7), Monoclonal and Polyclonal Antibodies Research(7), vaccines and immunoinformatics approaches(6), Alzheimer's disease research and treatments(4)

Publications47 total

Alzheimer’s Disease: A Brief History of Immunotherapies Targeting Amyloid β
International Journal of Molecular Sciences·2023· 72 citedOpen Access
A scalable and highly immunogenic virus‐like particle‐based vaccine against SARS‐CoV‐2
Allergy·2021· 54 citedOpen Access
A scalable and highly immunogenic virus-like particle-based vaccine against SARS-CoV-2
2021· 3 citedOpen Access
Immunization of Cats against Fel d 1 Results in Reduced Allergic Symptoms of Owners
Viruses·2020· 35 citedOpen Access
Immunization of cats to induce neutralizing antibodies against Fel d 1, the major feline allergen in human subjects
Journal of Allergy and Clinical Immunology·2019· 66 citedOpen Access
A vaccine against Alzheimer`s disease: anything left but faith?
Expert Opinion on Biological Therapy·2018· 33 cited
Incorporation of tetanus-epitope into virus-like particles achieves vaccine responses even in older recipients in models of psoriasis, Alzheimer’s and cat allergy
npj Vaccines·2017· 103 citedOpen Access
Development of an Interleukin-1β Vaccine in Patients with Type 2 Diabetes
Molecular Therapy·2015· 73 citedOpen Access
Particle-based platforms for malaria vaccines
Vaccine·2015· 31 citedOpen Access
Preclinical efficacy and safety of an anti-IL-1β vaccine for the treatment of type 2 diabetes
Molecular Therapy — Methods & Clinical Development·2014· 58 citedOpen Access
Bacterially Produced Recombinant Influenza Vaccines Based on Virus-Like Particles
PLoS ONE·2013· 46 citedOpen Access
A VLP‐based vaccine against interleukin‐1α protects mice from atherosclerosis
European Journal of Immunology·2012· 31 citedOpen Access
Therapeutic vaccines for chronic diseases: successes and technical challenges
Philosophical Transactions of the Royal Society B Biological Sciences·2011· 69 citedOpen Access
The Second-Generation Active A  Immunotherapy CAD106 Reduces Amyloid Accumulation in APP Transgenic Mice While Minimizing Potential Side Effects
Journal of Neuroscience·2011· 190 citedOpen Access
A Virus-Like Particle-Based Anti-Nerve Growth Factor Vaccine Reduces Inflammatory Hyperalgesia: Potential Long-Term Therapy for Chronic Pain
The Journal of Immunology·2010· 34 citedOpen Access
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
Nature reviews. Immunology·2010· 2.0k cited
A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice
Virology Journal·2010· 98 citedOpen Access
Versatile Virus-Like Particle Carrier for Epitope Based Vaccines
PLoS ONE·2010· 197 citedOpen Access
Combined vaccination against IL-5 and eotaxin blocks eosinophilia in mice
Vaccine·2010· 27 cited
Immunodrugs: Therapeutic VLP-Based Vaccines for Chronic Diseases
The Annual Review of Pharmacology and Toxicology·2008· 123 cited
page 1 of 3Next →

Frequent Co-authors

Martin F. Bachmann(38), Rainer G. Ulrich(16), Detlev H. Krüger(15), Alain C. Tissot(14), Patrik Maurer(12), Paul Pumpens(12), Wolfgang A. Renner(7), Gunther Spohn(7), Andrea Jegerlehner(7), Velta Ose(6), Thomas M. Kündig(6), Franziska Lechner(6), Peter Sebbel(6), Monique Vogel(5), William L. Brown(5), Robert A. Mastico(5), Karen G. Heal(5), C.J. Adams(5), James B. Murray(5), Jeremy C. Simpson(5)